Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Vaccine hesitancy grows ahead of Thailand's mass inoculation rollout

Stock Markets May 25, 2021 04:40AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. A person receives China's Sinovac coronavirus disease (COVID-19) vaccine at the Central Vaccination Center, inside the Bang Sue Grand Station, in Bangkok, Thailand, May 24, 2021. REUTERS/Athit Perawongmetha

By Chayut Setboonsarng

BANGKOK (Reuters) - Vaccine hesitancy has risen sharply in Thailand opinion polls show, just weeks away from the start of a mass inoculation programme and as the country fights its deadliest COVID-19 outbreak.

Reasons for the rise in vaccine hesitancy were unclear in the polls, but there are widespread complaints at government disorganisation, delays in getting vaccines and reliance on Sinovac and locally made AstraZeneca (NASDAQ:AZN) doses.

Thailand has reported 135,439 infections and 832 deaths since the pandemic began last year.

In January, 83% of Thais surveyed by polling firm YouGov were willing to be vaccinated, but by May that dropped to 63% in the same poll, lower than Vietnam and the Philippines at 83% and 66% willingness, respectively.

Thai-based Suan Dusit Poll on Sunday echoed the YouGov findings of rising vaccine hesitancy, with 64% of respondents willing to be vaccinated, compared with 66% in January.

Dissatisfaction with the military-backed government's vaccine strategy has been building for months.

"People are worried about the vaccines that the government procured. It's not that we don't want to get shots, but there is hesitancy," Facebook (NASDAQ:FB) user Than Tongkum wrote under a government announcement encouraging vaccinations.

Asked by Suan Dusit poll for their views on Thai vaccinations, only 57% of respondents believed they would help develop immunity and reduce the virus impact, while 59% worried about side-effects.

With Thailand's main vaccination drive, which is due to start June 7, relying heavily on AstraZeneca, respondents had 66% confidence in the shot, fourth behind U.S.-developed vaccines, with Pfizer (NYSE:PFE) top at 75%.

Thailand aims to inoculate 70% of its population by year-end, a level its tourist hotspots must also reach locally before reopening to vaccinated foreign visitors.

Registration is ongoing for the first 16 million people including those over 60 or with health conditions.

So far, 7.8 million people have registered.

Government spokesman Anucha Burapachaisri said he believes the vaccines will be embraced once the inoculation programme starts.

"As Thailand receives more doses, there will be more vaccine sites, which will help create awareness among the public after they see large numbers of vaccinations do not lead to serious side effects," he told Reuters.

Actress Araya "Chompoo" Hargate sparked controversy after she posted to her 10.5 million followers on Instagram saying she chose Sinovac.

"Can't help but think this is government PR," wrote user iloveurdadmaybe.

Among the concerns is perception that Sinovac has a low efficacy rate.

"Just hearing that it's Sinovac that's only 50% safe and 50% effective," wrote Facebook user Dang Juntawan.

"Injections are on chance. If you're unlucky you'll die."

Vaccine hesitancy grows ahead of Thailand's mass inoculation rollout
 

Related Articles

NASA chief Bill Nelson tests positive for COVID
NASA chief Bill Nelson tests positive for COVID By Reuters - Jun 29, 2022

By Joey Roulette WASHINGTON (Reuters) - NASA administrator Bill Nelson tested positive for COVID-19 on Tuesday night, the U.S. space agency chief said on Wednesday. Nelson was...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email